Donovan Weighs in on the Defining Pandemic Moments For Health And Life Science Attorneys
March 11, 2021
Law360
Partner Christopher J. Donovan was quoted in a Law360 article titled, “The Defining Pandemic Moments For Health And Life Sci Attys.” The article solicited recollections from attorneys about the unprecedented impacts of the COVID-19 pandemic and how it tested and profoundly reshaped our health care and life sciences systems.
One such impact was a decline in health care M&A activity in early months of the pandemic. However, Donovan told Law360 that M&A “came back with a vengeance in Q3-Q4 of 2020. He added that the shift to virtual meetings provided greater flexibility for bankers and PE investors who could suddenly, “”visit four cities in one day” for meetings, Donovan added.
People
Related News
August 13, 2025
In the News
Leigh Riley on Elevating Partner Development with Foley's PEAK Program – 'We can't stop learning'
Foley & Lardner LLP partner Leigh Riley appeared on the Big Law Life podcast to share how Foley is redefining professional development to meet the needs of the firm's partners and the demands of modern legal practice.
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."